NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-106-2014-0-GB-21 YEAST-BASED IMMUNOTHERAPY FOR CHORDOMA GB EP 14797995.9 Issued
NCI E-106-2014-0-IL-09 YEAST-BASED IMMUNOTHERAPY FOR CHORDOMA IL National Stage 241384 Issued
NCI E-106-2014-0-US-16 YEAST-BASED IMMUNOTHERAPY FOR CHORDOMA US National Stage 14/778,118 10507235 Issued PDF
NCI E-106-2014-0-TW-03 YEAST-BASED IMMUNOTHERAPY FOR CHORDOMA TW ORD 103110360 Issued
NCI E-106-2014-0-AU-04 YEAST-BASED IMMUNOTHERAPY FOR CHORDOMA AU National Stage 2014265873 Issued
NCI E-106-2014-0-JP-10 YEAST-BASED IMMUNOTHERAPY FOR CHORDOMA JP National Stage 2016-504343 Issued
NCI E-106-2014-0-RU-14 YEAST-BASED IMMUNOTHERAPY FOR CHORDOMA RU National Stage 2015144511 Issued
NCI E-106-2014-0-BR-05 YEAST-BASED IMMUNOTHERAPY FOR CHORDOMA BR National Stage BR112015023968-4 Pending
NCI E-106-2014-0-PCT-02 The Development And Use Of A Recombinant Brachyury Saccharomyces Cerevisiae (yeast) Vaccine For The Prevention And/or Therapy Of Chordoma PCT PCT PCT/US2014/031183 Expired
CC E-059-2015-0-US-01 NOVEL ULTRASOUND IMAGEABLE LOW TEMPERATURE SENSITIVE LIPOSOMES FOR REAL-TIME CONTROL AND MAPPING OF TUMOR DRUG DELIVERY US 61/944,106 Abandoned
NCATS E-046-2013-10-US-01 ANTIFUNGAL COMPOUND PROCESS US 61/955,650 Abandoned
NCATS E-046-2013-9-US-01 ANTIFUNGAL COMPOUND PROCESS US 61/955,633 Abandoned
NCATS E-022-2016-0-US-01 Antifungal Compound Process US 61/955,633 Abandoned
NCATS E-046-2013-6-US-01 ANTIFUNGAL COMPOUND PROCESS US 61/955,568 Abandoned
NCATS E-046-2013-5-US-01 ANTIFUNGAL COMPOUND PROCESS US 61/955,532 Abandoned
NCATS E-046-2013-7-US-01 ANTIFUNGAL COMPOUND PROCESS US 61/955,599 Abandoned
NCATS E-021-2016-0-US-01 Antifungal Compound Process US 61/955,615 Abandoned
NCATS E-046-2013-8-US-01 ANTIFUNGAL COMPOUND PROCESS US 61/955,615 Abandoned
NCATS E-018-2016-0-US-01 Antifungal Compound Process US 61/955,532 Abandoned
NCATS E-023-2016-0-US-01 Antifungal Compound Process US 61/955,650 Abandoned
NCATS E-020-2016-0-US-01 Antifungal Compound Process US 61/955,599 Abandoned
NCATS E-019-2016-0-US-01 Antifungal Compound Process US 61/955,568 Abandoned
NCI E-106-2014-0-SG-15 YEAST-BASED IMMUNOTHERAPY FOR CHORDOMA SG National Stage 11201507328R Pending
NCI E-106-2014-0-KR-11 YEAST-BASED IMMUNOTHERAPY FOR CHORDOMA KR National Stage 10-2015-7030048 Abandoned
NIAID E-117-2013-1-CA-06 EPITOPE OF RSV FUSION PROTEIN AND ANTIBODY RECOGNIZING THE EPITOPE CA National Stage 2906960 Issued
NIAID E-117-2013-1-EP-03 Epitope of RSV Fusion Protein and Antibody Identifying Same EP National Stage 14765573.2 Issued
NIAID E-117-2013-1-JP-08 Epitope of RSV Fusion Protein and Antibody Identifying Same JP National Stage 2015561931 Issued
NIAID E-117-2013-1-AU-05 Epitope of RSV Fusion Protein and Antibody Identifying Same AU National Stage 2014231357 Issued
NCI E-023-2009-0-US-04 Molecular-based method of Cancer Diagnosis and Prognosis US DIV 14/215,574 9181589 Issued PDF
NIAID E-117-2013-1-PCT-01 Epitope of RSV Fusion Protein and Antibody Identifying Same PCT PCT PCT/CN2014/073505 Expired
NIAID E-117-2013-1-IN-07 Epitope of RSV Fusion Protein and Antibody Identifying Same IN National Stage 8928/DELNP/2015 Pending
NCATS E-023-2013-0-PCT-02 NRF2 SMALL MOLECULE INHIBITORS FOR CANCER THERAPY PCT PCT PCT/US2014/030442 Expired
NIAMS E-011-2005-0-US-16 Cross-linked Polymer Matrices, And Methods Of Making And Using Same US CON 14/215,270 Abandoned
NICHD E-187-2012-0-US-01 Methods of Treating Glioblastoma Multiforme (GBM) And Other Cancers Using Induced Electric Fields US 61/954,494 Abandoned
NIAAA E-316-2013-0-US-02 Process for producing (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate US ORD 14/213,713 11566268 Issued PDF
CC E-184-2012-0-CA-06 Synthesis And Characterization Of Image-able Polyvinyl Alcohol Microspheres For Chemoembolization And X-ray-based Imaging CA National Stage 2906574 Issued
NIAAA E-316-2013-0-BR-05 Process for producing (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate BR National Stage BR112015023334-1 Issued
NIAAA E-316-2013-0-CA-06 Process for producing (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate CA National Stage 2905225 Issued
NIAAA E-316-2013-0-IN-10 Process for producing (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate IN National Stage 2675/MUMNP/2015 Issued
CC E-184-2012-0-US-05 Synthesis And Characterization Of Image-able Polyvinyl Alcohol Microspheres For Chemoembolization And X-ray-based Imaging US National Stage 14/777,168 10307493 Issued PDF
CC E-184-2012-0-JP-04 Synthesis And Characterization Of Image-able Polyvinyl Alcohol Microspheres For Chemoembolization And X-ray-based Imaging JP National Stage 2016-502420 Issued
NCI E-266-2011-0-JP-06 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage JP National Stage 2053-07-31 Issued
NIAAA E-316-2013-0-AU-04 Process for producing (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate AU National Stage 2014230120 Issued
NCI E-266-2011-0-AT-15 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage AT EP 12761862.7 Issued
NCI E-266-2011-0-BE-16 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage BE EP 12761862.7 Issued
NCI E-266-2011-0-CZ-18 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage CZ EP 12761862.7 Issued
NCI E-266-2011-0-GB-20 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage GB EP 12761862.7 Issued
NCI E-266-2011-0-TR-31 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage TR EP 12761862.7 Issued
NCI E-266-2011-0-CH-17 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage CH EP 12761862.7 Issued
NCI E-266-2011-0-NL-24 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage NL EP 12761862.7 Issued